David Morrow, MD, MPH

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Merck & Co
    Topic:
    Cardiovascular therapeutics
    Date added:
    02/08/2026
    Date updated:
    02/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Novartis
    Topic:
    Cardiovascular therapeutics
    Date added:
    02/08/2026
    Date updated:
    02/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Regeneron
    Topic:
    Cardiovascular therapeutics
    Date added:
    02/08/2026
    Date updated:
    02/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Roche
    Topic:
    Cardiovascular therapeutics
    Date added:
    02/08/2026
    Date updated:
    02/08/2026

Pages

Return to 2026 Inova Fairfax Medicine Grand Rounds